This study constructed a prognostic risk signature based on SPRGs in gastric cancer, which is closely related to clinical pathological features, drug sensitivity, and immune landscape, providing new insights for personalized treatment.
Wei ShaoZongcheng YangYue FuLixin ZhengFen LiuLi ChaiJihui Jia
Tsz Kin MakXing LiHuaping HuangKaiming WuZhijian HuangYulong HeChanghua Zhang
Lijian HeQiange YeYanmei ZhuZhong WenqiGuifang XuLei WangZhangding WangXiaoping Zou
Yulian ZhangChuanpeng ZhangYanbo YangGuohui WangZai WangJiang LiuLi ZhangYanbing Yu